The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in ...

In response to this season’s high flu activity and the ongoing avian flu outbreaks, the Centers for Disease Control and Prevention (CDC) has advised clinicians and laboratories to conduct subtype ...

Quickly and accurately identifying which microbe is causing a patient’s disease is key to developing the proper treatment.

The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.

"What a boon this will be to downtown Topeka," said Janet Stanek, the KDHE secretary, of the new Kansas health and ...

Eric Siegel, a Ph.D. student in microbiologist Stephen Rich’s Laboratory of Medical Zoology and at the UMass Amherst-based New England Center of Excellence in Vector-borne Diseases (NEWVEC), has been ...

Governor Laura Kelly joined Kansas Department of Health and Environment Secretary Janet Stanek, state and local leaders, and ...

Biotech Clever Culture Systems has made a significant strategic pivot to target big pharma customers, and it looks like the .

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...

My name is John MacSharry, and I lecture medical microbiology at UCC. I am also a member of the APC Microbiome Ireland Research Team and a Research Partner of Atlantia Food and Clinical Trials.